CAL02, a novel antitoxin liposomal agent, in severe...

  • Main
  • 2019 / 5
  • CAL02, a novel antitoxin liposomal agent, in severe...
The Lancet Infectious Diseases 2019 / 5

CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial

Laterre, Pierre-François, Colin, Gwenhael, Dequin, Pierre-François, Dugernier, Thierry, Boulain, Thierry, Azeredo da Silveira, Samareh, Lajaunias, Frédéric, Perez, Antonio, François, Bruno
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The Lancet Infectious Diseases
DOI:
10.1016/S1473-3099(18)30805-3
Date:
May, 2019
File:
PDF, 280 KB
english, 2019
Conversion to is in progress
Conversion to is failed